Last 12 months
Inside the activity.
0 purchase rows · 313 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 114 |
| Dec 2025 | 0 | 16 |
| Jan 2026 | 0 | 16 |
| Feb 2026 | 0 | 55 |
| Mar 2026 | 0 | 9 |
| Apr 2026 | 0 | 24 |
| May 2026 | 0 | 45 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 19 |
| Aug 2026 | 0 | 6 |
| Sep 2026 | 0 | 8 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 14, 2022 Filed Feb 16, 2022 23:44 UTC |
Tseng SariaVP & General Counsel
|
SaleCommon Stock | 1,663 | $429.60 | $714,424.80 |
DisclosureSEC source: 0001214659-22-002837 · marketforms-55211.xml · nonDerivative · entry 1 Tseng Saria · CIK 0001312593 · VP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 275,546 F1 · shares: The reported sales were to cover taxes upon the vesting of restricted stock units, as required by the Company's equity incentive plan. Read SEC document |
| February 14, 2022 Filed Feb 16, 2022 23:44 UTC |
Sciammas MauriceSr. V.P.of Sales and Marketing
|
SaleCommon Stock | 1,663 | $429.60 | $714,424.80 |
DisclosureSEC source: 0001214659-22-002836 · marketforms-55212.xml · nonDerivative · entry 1 Sciammas Maurice · CIK 0001360833 · Sr. V.P.of Sales and Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 273,597 F1 · shares: The reported sales were to cover taxes upon the vesting of restricted stock units, as required by the Company's equity incentive plan. Read SEC document |
| February 08, 2022 Filed Feb 9, 2022 19:01 UTC |
Martinez CarintiaDirector
|
GrantCommon Stock | 542 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-22-002141 · marketforms-55218.xml · nonDerivative · entry 1 Martinez Carintia · CIK 0001865213 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,125 F1 · shares: On February 8, 2022, the Board of Directors approved the annual restricted stock unit grant of 542 shares to each independent director. The RSU grant will vest one year after the grant date, subject to continued service with the company. Read SEC document |
| February 08, 2022 Filed Feb 10, 2022 00:01 UTC |
Zhou JeffDirector
|
GrantCommon Stock | 542 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-22-002140 · marketforms-55217.xml · nonDerivative · entry 1 Zhou Jeff · CIK 0001480772 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,051 F1 · shares: On February 8, 2022, the Board of Directors approved the annual restricted stock unit grant of 542 shares to each independent director. The RSU grant will vest one year after the grant date, subject to continued service with the company. Read SEC document |
| February 08, 2022 Filed Feb 9, 2022 23:22 UTC | SaleCommon stock | 1,117 | $401.12 | $448,051.04 |
DisclosureSEC source: 0001214659-22-002125 · marketforms-55039.xml · nonDerivative · entry 2 BLEGEN THEODORE · CIK 0001415033 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 136,039 F1 · shares: The reported sales were to cover taxes upon the vesting of restricted stock units, as required by the Company's equity incentive plan. Read SEC document |
|
| February 08, 2022 Filed Feb 9, 2022 18:59 UTC |
Lee Victor KDirector
|
GrantCommon Stock | 542 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-22-002137 · marketforms-55215.xml · nonDerivative · entry 1 Lee Victor K · CIK 0001292133 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,414 F1 · shares: On February 8, 2022, the Board of Directors approved the annual restricted stock unit grant of 542 shares to each independent director. The RSU grant will vest one year after the grant date, subject to continued service with the company. Read SEC document |
| February 08, 2022 Filed Feb 10, 2022 00:00 UTC |
Elmiger Eugen JDirector
|
GrantCommon Stock | 542 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-22-002138 · marketforms-55214.xml · nonDerivative · entry 1 Elmiger Eugen J · CIK 0001560945 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,060 F1 · shares: On February 8, 2022, the Board of Directors approved the annual restricted stock unit grant of 542 shares to each independent director. The RSU grant will vest one year after the grant date, subject to continued service with the company. Read SEC document |
| February 08, 2022 Filed Feb 10, 2022 00:00 UTC |
Moyer James CDirector
|
GrantCommon Stock | 542 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-22-002139 · marketforms-55216.xml · nonDerivative · entry 1 Moyer James C · CIK 0001308656 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 234,383 F1 · shares: On February 8, 2022, the Board of Directors approved the annual restricted stock unit grant of 542 shares to each independent director. The RSU grant will vest one year after the grant date, subject to continued service with the company. Read SEC document |
| February 08, 2022 Filed Feb 9, 2022 23:59 UTC |
CHANG KUO WEI HERBERTDirector
|
GrantCommon Stock | 542 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-22-002136 · marketforms-55213.xml · nonDerivative · entry 1 CHANG KUO WEI HERBERT · CIK 0001192171 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,356 F1 · shares: On February 8, 2022, the Board of Directors approved the annual restricted stock unit grant of 542 shares to each independent director. The RSU grant will vest one year after the grant date, subject to continued service with the company. Read SEC document |
| February 08, 2022 Filed Feb 9, 2022 23:23 UTC |
Xiao DemingPres. of MPS Asia Operations
|
SaleCommon Stock | 1,700 | $401.12 | $681,904.00 |
DisclosureSEC source: 0001214659-22-002128 · marketforms-55037.xml · nonDerivative · entry 2 Xiao Deming · CIK 0001308647 · Pres. of MPS Asia Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 301,138 F1 · shares: The reported sales were to cover taxes upon the vesting of restricted stock units, as required by the Company's equity incentive plan. Read SEC document |
| February 08, 2022 Filed Feb 9, 2022 23:24 UTC |
Tseng SariaVP & General Counsel
|
SaleCommon Stock | 1,700 | $401.12 | $681,904.00 |
DisclosureSEC source: 0001214659-22-002129 · marketforms-55210.xml · nonDerivative · entry 2 Tseng Saria · CIK 0001312593 · VP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 277,209 F1 · shares: The reported sales were to cover taxes upon the vesting of restricted stock units, as required by the Company's equity incentive plan. Read SEC document |
| February 08, 2022 Filed Feb 9, 2022 23:23 UTC |
Sciammas MauriceSr. V.P.of Sales and Marketing
|
SaleCommon Stock | 1,700 | $401.12 | $681,904.00 |
DisclosureSEC source: 0001214659-22-002127 · marketforms-55167.xml · nonDerivative · entry 2 Sciammas Maurice · CIK 0001360833 · Sr. V.P.of Sales and Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 275,260 F1 · shares: The reported sales were to cover taxes upon the vesting of restricted stock units, as required by the Company's equity incentive plan. Read SEC document |
| February 08, 2022 Filed Feb 9, 2022 23:22 UTC |
Hsing MichaelDirector · CEO
|
SaleCommon Stock | 7,663 | $401.12 | $3,073,782.56 |
DisclosureSEC source: 0001214659-22-002126 · marketforms-55162.xml · nonDerivative · entry 2 Hsing Michael · CIK 0001308676 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,066,348 F1 · shares: The reported sales were to cover taxes upon the vesting of restricted stock units, as required by the Company's equity incentive plan. Read SEC document |
| February 07, 2022 Filed Feb 9, 2022 23:22 UTC | SaleCommon Stock | 6,336 | $399.28 | $2,529,838.08 |
DisclosureSEC source: 0001214659-22-002125 · marketforms-55039.xml · nonDerivative · entry 1 BLEGEN THEODORE · CIK 0001415033 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 137,156 F1 · shares: The reported sales were to cover taxes upon the vesting of restricted stock units, as required by the Company's equity incentive plan. Read SEC document |
|
| February 07, 2022 Filed Feb 9, 2022 23:23 UTC |
Xiao DemingPres. of MPS Asia Operations
|
SaleCommon Stock | 7,393 | $399.28 | $2,951,877.04 |
DisclosureSEC source: 0001214659-22-002128 · marketforms-55037.xml · nonDerivative · entry 1 Xiao Deming · CIK 0001308647 · Pres. of MPS Asia Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 302,838 F1 · shares: The reported sales were to cover taxes upon the vesting of restricted stock units, as required by the Company's equity incentive plan. Read SEC document |
| February 07, 2022 Filed Feb 9, 2022 23:24 UTC |
Tseng SariaVP & General Counsel
|
SaleCommon Stock | 7,393 | $399.28 | $2,951,877.04 |
DisclosureSEC source: 0001214659-22-002129 · marketforms-55210.xml · nonDerivative · entry 1 Tseng Saria · CIK 0001312593 · VP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 278,909 F1 · shares: The reported sales were to cover taxes upon the vesting of restricted stock units, as required by the Company's equity incentive plan. Read SEC document |
| February 07, 2022 Filed Feb 9, 2022 23:23 UTC |
Sciammas MauriceSr. V.P.of Sales and Marketing
|
SaleCommon Stock | 8,144 | $399.28 | $3,251,736.32 |
DisclosureSEC source: 0001214659-22-002127 · marketforms-55167.xml · nonDerivative · entry 1 Sciammas Maurice · CIK 0001360833 · Sr. V.P.of Sales and Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 276,960 F1 · shares: The reported sales were to cover taxes upon the vesting of restricted stock units, as required by the Company's equity incentive plan. Read SEC document |
| February 07, 2022 Filed Feb 9, 2022 23:22 UTC |
Hsing MichaelDirector · CEO
|
SaleCommon Stock | 29,638 | $399.28 | $11,833,860.64 |
DisclosureSEC source: 0001214659-22-002126 · marketforms-55162.xml · nonDerivative · entry 1 Hsing Michael · CIK 0001308676 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,074,011 F1 · shares: The reported sales were to cover taxes upon the vesting of restricted stock units, as required by the Company's equity incentive plan. Read SEC document |
| February 03, 2022 Filed Feb 4, 2022 22:05 UTC | Grantcommon stock | 27,174 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-22-001920 · marketforms-55259.xml · nonDerivative · entry 1 BLEGEN THEODORE · CIK 0001415033 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 143,492 F1 · shares: On February 4, 2020, the reporting person was granted a target of 9,058 shares of restricted stock units, with the right to earn up to 300% of the target shares, subject to satisfaction of pre-determined, performance-based vesting criteria. On February 3, 2022, the Company's Compensation Committee of the Board of Directors determined and approved the achievement of the performance criteria for the restricted stock units, which resulted in 18,116 additional shares being earned by the reporting person. Of the restricted stock units that were awarded, 13,587 will vest immediately and 13,587 will vest quarterly in the next two years. Read SEC document |
|
| February 03, 2022 Filed Feb 4, 2022 22:07 UTC |
Xiao DemingPres. of MPS Asia Operations
|
GrantCommon Stock | 39,699 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-22-001924 · marketforms-55265.xml · nonDerivative · entry 1 Xiao Deming · CIK 0001308647 · Pres. of MPS Asia Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 310,231 F1 · shares: On February 4, 2020, the reporting person was granted a target of 13,233 shares of restricted stock units, with the right to earn up to 300% of the target shares, subject to satisfaction of pre-determined, performance-based vesting criteria. On February 3, 2022, the Company's Compensation Committee of the Board of Directors determined and approved the achievement of the performance criteria for the restricted stock units, which resulted in 26,466 additional shares being earned by the reporting person. Of the restricted stock units that were awarded, 19,851 will vest immediately and 19,848 will vest quarterly in the next two years. Read SEC document |
| February 03, 2022 Filed Feb 4, 2022 22:06 UTC |
Tseng SariaVP & General Counsel
|
GrantCommon Stock | 39,699 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-22-001923 · marketforms-55264.xml · nonDerivative · entry 1 Tseng Saria · CIK 0001312593 · VP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 286,302 F1 · shares: On February 4, 2020, the reporting person was granted a target of 13,233 shares of restricted stock units, with the right to earn up to 300% of the target shares, subject to satisfaction of pre-determined, performance-based vesting criteria. On February 3, 2022, the Company's Compensation Committee of the Board of Directors determined and approved the achievement of the performance criteria for the restricted stock units, which resulted in 26,466 additional shares being earned by the reporting person. Of the restricted stock units that were awarded, 19,851 will vest immediately and 19,848 will vest quarterly in the next two years. Read SEC document |
| February 03, 2022 Filed Feb 4, 2022 22:06 UTC |
Sciammas MauriceSr. V.P.of Sales and Marketing
|
GrantCommon Stock | 39,699 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-22-001922 · marketforms-55262.xml · nonDerivative · entry 1 Sciammas Maurice · CIK 0001360833 · Sr. V.P.of Sales and Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 285,104 F1 · shares: On February 4, 2020, the reporting person was granted a target of 13,233 shares of restricted stock units, with the right to earn up to 300% of the target shares, subject to satisfaction of pre-determined, performance-based vesting criteria. On February 3, 2022, the Company's Compensation Committee of the Board of Directors determined and approved the achievement of the performance criteria for the restricted stock units, which resulted in 26,466 additional shares being earned by the reporting person. Of the restricted stock units that were awarded, 19,851 will vest immediately and 19,848 will vest quarterly in the next two years. Read SEC document |
| February 03, 2022 Filed Feb 4, 2022 22:05 UTC |
Hsing MichaelDirector · CEO
|
GrantCommon Stock | 153,324 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-22-001921 · marketforms-55260.xml · nonDerivative · entry 1 Hsing Michael · CIK 0001308676 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,103,649 F1 · shares: On February 4, 2020, the reporting person was granted a target of 51,108 shares of restricted stock units, with the right to earn up to 300% of the target shares, subject to satisfaction of pre-determined, performance-based vesting criteria. On February 3, 2022, the Company's Compensation Committee of the Board of Directors determined and approved the achievement of the performance criteria for the restricted stock units, which resulted in 102,216 additional shares being earned by the reporting person. Of the restricted stock units that were awarded, 76,662 will vest immediately and 76,662 will vest quarterly in the next two years. Read SEC document |
| January 20, 2022 Filed Jan 24, 2022 22:15 UTC | SaleCommon Stock | 30 | $424.14 | $12,724.20 |
DisclosureSEC source: 0001214659-22-001045 · marketforms-55100.xml · nonDerivative · entry 16 BLEGEN THEODORE · CIK 0001415033 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 116,318 F1 · shares: Shares sold pursuant to the reporting person's 10b5-1 plan. F17 · price: The price is the weighted average sale price for the transactions reported on this line. The prices for the transactions reported on this line range from $423.92 to $424.58. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
|
| January 20, 2022 Filed Jan 24, 2022 22:15 UTC | SaleCommon Stock | 139 | $422.99 | $58,795.61 |
DisclosureSEC source: 0001214659-22-001045 · marketforms-55100.xml · nonDerivative · entry 15 BLEGEN THEODORE · CIK 0001415033 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 116,348 F1 · shares: Shares sold pursuant to the reporting person's 10b5-1 plan. F16 · price: The price is the weighted average sale price for the transactions reported on this line. The prices for the transactions reported on this line range from $422.85 to $423.25. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
|
| January 20, 2022 Filed Jan 24, 2022 22:15 UTC | SaleCommon Stock | 245 | $422.31 | $103,465.95 |
DisclosureSEC source: 0001214659-22-001045 · marketforms-55100.xml · nonDerivative · entry 14 BLEGEN THEODORE · CIK 0001415033 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 116,487 F1 · shares: Shares sold pursuant to the reporting person's 10b5-1 plan. F15 · price: The price is the weighted average sale price for the transactions reported on this line. The prices for the transactions reported on this line range from $421.80 to $422.74. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
|
| January 20, 2022 Filed Jan 24, 2022 22:15 UTC | SaleCommon Stock | 220 | $421.18 | $92,659.60 |
DisclosureSEC source: 0001214659-22-001045 · marketforms-55100.xml · nonDerivative · entry 13 BLEGEN THEODORE · CIK 0001415033 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 116,732 F1 · shares: Shares sold pursuant to the reporting person's 10b5-1 plan. F14 · price: The price is the weighted average sale price for the transactions reported on this line. The prices for the transactions reported on this line range from $420.80 to $421.74. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
|
| January 20, 2022 Filed Jan 24, 2022 22:15 UTC | SaleCommon Stock | 220 | $419.85 | $92,367.00 |
DisclosureSEC source: 0001214659-22-001045 · marketforms-55100.xml · nonDerivative · entry 12 BLEGEN THEODORE · CIK 0001415033 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 116,952 F1 · shares: Shares sold pursuant to the reporting person's 10b5-1 plan. F13 · price: The price is the weighted average sale price for the transactions reported on this line. The prices for the transactions reported on this line range from $419.52 to $420.30. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
|
| January 20, 2022 Filed Jan 24, 2022 22:15 UTC | SaleCommon Stock | 58 | $418.72 | $24,285.76 |
DisclosureSEC source: 0001214659-22-001045 · marketforms-55100.xml · nonDerivative · entry 11 BLEGEN THEODORE · CIK 0001415033 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 117,172 F1 · shares: Shares sold pursuant to the reporting person's 10b5-1 plan. F12 · price: The price is the weighted average sale price for the transactions reported on this line. The prices for the transactions reported on this line range from $418.30 to $419.16. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
|
| January 20, 2022 Filed Jan 24, 2022 22:15 UTC | SaleCommon Stock | 40 | $417.29 | $16,691.60 |
DisclosureSEC source: 0001214659-22-001045 · marketforms-55100.xml · nonDerivative · entry 10 BLEGEN THEODORE · CIK 0001415033 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 117,230 F1 · shares: Shares sold pursuant to the reporting person's 10b5-1 plan. F11 · price: The price is the weighted average sale price for the transactions reported on this line. The prices for the transactions reported on this line range from $417.09 to $417.48. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
|
| January 20, 2022 Filed Jan 24, 2022 22:15 UTC | SaleCommon Stock | 60 | $416.48 | $24,988.80 |
DisclosureSEC source: 0001214659-22-001045 · marketforms-55100.xml · nonDerivative · entry 9 BLEGEN THEODORE · CIK 0001415033 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 117,270 F1 · shares: Shares sold pursuant to the reporting person's 10b5-1 plan. F10 · price: The price is the weighted average sale price for the transactions reported on this line. The prices for the transactions reported on this line range from $416.01 to $416.92. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
|
| January 20, 2022 Filed Jan 24, 2022 22:15 UTC | SaleCommon Stock | 107 | $415.35 | $44,442.45 |
DisclosureSEC source: 0001214659-22-001045 · marketforms-55100.xml · nonDerivative · entry 8 BLEGEN THEODORE · CIK 0001415033 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 117,330 F1 · shares: Shares sold pursuant to the reporting person's 10b5-1 plan. F9 · price: The price is the weighted average sale price for the transactions reported on this line. The prices for the transactions reported on this line range from $414.77 to $415.71. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
|
| January 20, 2022 Filed Jan 24, 2022 22:15 UTC | SaleCommon Stock | 40 | $412.94 | $16,517.60 |
DisclosureSEC source: 0001214659-22-001045 · marketforms-55100.xml · nonDerivative · entry 7 BLEGEN THEODORE · CIK 0001415033 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 117,437 F1 · shares: Shares sold pursuant to the reporting person's 10b5-1 plan. F8 · price: The price is the weighted average sale price for the transactions reported on this line. The prices for the transactions reported on this line range from $412.21 to $413.67. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
|
| January 20, 2022 Filed Jan 24, 2022 22:15 UTC | SaleCommon Stock | 40 | $411.53 | $16,461.20 |
DisclosureSEC source: 0001214659-22-001045 · marketforms-55100.xml · nonDerivative · entry 6 BLEGEN THEODORE · CIK 0001415033 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 117,477 F1 · shares: Shares sold pursuant to the reporting person's 10b5-1 plan. F7 · price: The price is the weighted average sale price for the transactions reported on this line. The prices for the transactions reported on this line range from $411.11 to $411.94. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
|
| January 20, 2022 Filed Jan 24, 2022 22:15 UTC | SaleCommon Stock | 60 | $408.89 | $24,533.40 |
DisclosureSEC source: 0001214659-22-001045 · marketforms-55100.xml · nonDerivative · entry 5 BLEGEN THEODORE · CIK 0001415033 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 117,517 F1 · shares: Shares sold pursuant to the reporting person's 10b5-1 plan. F6 · price: The price is the weighted average sale price for the transactions reported on this line. The prices for the transactions reported on this line range from $408.60 to $409.05. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
|
| January 20, 2022 Filed Jan 24, 2022 22:15 UTC | SaleCommon Stock | 40 | $407.77 | $16,310.80 |
DisclosureSEC source: 0001214659-22-001045 · marketforms-55100.xml · nonDerivative · entry 4 BLEGEN THEODORE · CIK 0001415033 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 117,577 F1 · shares: Shares sold pursuant to the reporting person's 10b5-1 plan. F5 · price: The price is the weighted average sale price for the transactions reported on this line. The prices for the transactions reported on this line range from $407.545 to $407.98. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
|
| January 20, 2022 Filed Jan 24, 2022 22:15 UTC | SaleCommon Stock | 60 | $406.31 | $24,378.60 |
DisclosureSEC source: 0001214659-22-001045 · marketforms-55100.xml · nonDerivative · entry 3 BLEGEN THEODORE · CIK 0001415033 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 117,617 F1 · shares: Shares sold pursuant to the reporting person's 10b5-1 plan. F4 · price: The price is the weighted average sale price for the transactions reported on this line. The prices for the transactions reported on this line range from $406.15 to $406.44. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
|
| January 20, 2022 Filed Jan 24, 2022 22:15 UTC | SaleCommon Stock | 100 | $405.36 | $40,536.00 |
DisclosureSEC source: 0001214659-22-001045 · marketforms-55100.xml · nonDerivative · entry 2 BLEGEN THEODORE · CIK 0001415033 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 117,677 F1 · shares: Shares sold pursuant to the reporting person's 10b5-1 plan. F3 · price: The price is the weighted average sale price for the transactions reported on this line. The prices for the transactions reported on this line range from $405.15 to $405.46. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
|
| January 20, 2022 Filed Jan 24, 2022 22:15 UTC | SaleCommon Stock | 438 | $404.25 | $177,062.90 |
DisclosureSEC source: 0001214659-22-001045 · marketforms-55100.xml · nonDerivative · entry 1 BLEGEN THEODORE · CIK 0001415033 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 117,777 F1 · shares: Shares sold pursuant to the reporting person's 10b5-1 plan. F2 · price: The price is the weighted average sale price for the transactions reported on this line. The prices for the transactions reported on this line range from $404.06 to $404.81. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
|
| January 03, 2022 Filed Jan 5, 2022 21:11 UTC | SaleCommon Stock | 905 | $490.87 | $444,237.35 |
DisclosureSEC source: 0001214659-22-000326 · marketforms-54754.xml · nonDerivative · entry 1 BLEGEN THEODORE · CIK 0001415033 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 118,215 F1 · shares: The reported sales were to cover taxes upon the vesting of restricted stock units, as required by the Company's equity incentive plan. Read SEC document |
|
| January 03, 2022 Filed Jan 5, 2022 21:12 UTC |
Sciammas MauriceSr. V.P.of Sales and Marketing
|
SaleCommon Stock | 4,305 | $490.87 | $2,113,195.35 |
DisclosureSEC source: 0001214659-22-000328 · marketforms-54756.xml · nonDerivative · entry 1 Sciammas Maurice · CIK 0001360833 · Sr. V.P.of Sales and Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 245,405 F1 · shares: The reported sales were to cover taxes upon the vesting of restricted stock units, as required by the Company's equity incentive plan. Read SEC document |
| January 03, 2022 Filed Jan 5, 2022 21:11 UTC |
Xiao DemingPres. of MPS Asia Operations
|
SaleCommon Stock | 4,305 | $490.87 | $2,113,195.35 |
DisclosureSEC source: 0001214659-22-000327 · marketforms-54758.xml · nonDerivative · entry 1 Xiao Deming · CIK 0001308647 · Pres. of MPS Asia Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 270,532 F1 · shares: The reported sales were to cover taxes upon the vesting of restricted stock units, as required by the Company's equity incentive plan. Read SEC document |
| January 03, 2022 Filed Jan 5, 2022 21:11 UTC |
Hsing MichaelDirector · CEO
|
SaleCommon Stock | 10,960 | $490.87 | $5,379,935.20 |
DisclosureSEC source: 0001214659-22-000325 · marketforms-54755.xml · nonDerivative · entry 1 Hsing Michael · CIK 0001308676 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 950,325 F1 · shares: The reported sales were to cover taxes upon the vesting of restricted stock units, as required by the Company's equity incentive plan. Read SEC document |
| January 03, 2022 Filed Jan 5, 2022 21:10 UTC |
Tseng SariaVP & General Counsel
|
SaleCommon Stock | 4,305 | $490.87 | $2,113,195.35 |
DisclosureSEC source: 0001214659-22-000324 · marketforms-54757.xml · nonDerivative · entry 1 Tseng Saria · CIK 0001312593 · VP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 246,603 F1 · shares: The reported sales were to cover taxes upon the vesting of restricted stock units, as required by the Company's equity incentive plan. F2 · balance_after: Ending balance adjusted by 1 share to correct the reported number of shares held by the reporting person. Read SEC document |
| December 20, 2021 Filed Dec 20, 2021 22:14 UTC | SaleCommon Stock | 1,897 | $474.35 | $899,841.95 |
DisclosureSEC source: 0001214659-21-013417 · marketforms-54753.xml · nonDerivative · entry 1 BLEGEN THEODORE · CIK 0001415033 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 119,120 F1 · kind: Shares sold pursuant to the reporting person's 10b5-1 plan. Read SEC document |
|
| November 30, 2021 Filed Dec 2, 2021 21:54 UTC |
Xiao DemingPres. of MPS Asia Operations
|
SaleCommon Stock | 4,366 | $560.00 | $2,444,960.00 |
DisclosureSEC source: 0001214659-21-012593 · marketforms-54419.xml · nonDerivative · entry 1 Xiao Deming · CIK 0001308647 · Pres. of MPS Asia Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 274,837 Read SEC document |
| November 22, 2021 Filed Nov 23, 2021 23:34 UTC | SaleCommon Stock | 45 | $579.26 | $26,066.70 |
DisclosureSEC source: 0001214659-21-012211 · marketforms-54378.xml · nonDerivative · entry 20 BLEGEN THEODORE · CIK 0001415033 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 121,017 F1 · kind: In accordance with the reporting person's 10b5-1 trading plan. F20 · price: The price is the weighted average sale price for the transactions reported on this line. The prices for the transactions reported on this line range from $578.77 to $579.76. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
|
| November 22, 2021 Filed Nov 23, 2021 23:34 UTC | SaleCommon Stock | 60 | $578.12 | $34,687.20 |
DisclosureSEC source: 0001214659-21-012211 · marketforms-54378.xml · nonDerivative · entry 19 BLEGEN THEODORE · CIK 0001415033 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 121,062 F1 · kind: In accordance with the reporting person's 10b5-1 trading plan. F19 · price: The price is the weighted average sale price for the transactions reported on this line. The prices for the transactions reported on this line range from $577.65 to $578.44. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
|
| November 22, 2021 Filed Nov 23, 2021 23:34 UTC | SaleCommon Stock | 140 | $577.24 | $80,813.60 |
DisclosureSEC source: 0001214659-21-012211 · marketforms-54378.xml · nonDerivative · entry 18 BLEGEN THEODORE · CIK 0001415033 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 121,122 F1 · kind: In accordance with the reporting person's 10b5-1 trading plan. F18 · price: The price is the weighted average sale price for the transactions reported on this line. The prices for the transactions reported on this line range from $576.65 to $577.60. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
|
| November 22, 2021 Filed Nov 23, 2021 23:34 UTC | SaleCommon Stock | 60 | $575.96 | $34,557.60 |
DisclosureSEC source: 0001214659-21-012211 · marketforms-54378.xml · nonDerivative · entry 17 BLEGEN THEODORE · CIK 0001415033 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 121,262 F1 · kind: In accordance with the reporting person's 10b5-1 trading plan. F17 · price: The price is the weighted average sale price for the transactions reported on this line. The prices for the transactions reported on this line range from $575.58 to $576.34. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.